Endocrine Abstracts

Objective: To determine the impact on quality of life and metabolic control of insulin pump therapy in a cohort of young people in south London.Methods: Seventeen children and young people with type 1 diabetes aged 5–17 undergoing assessment for pump therapy were routinely seen by a clinical psychologist as part of their assessment. The majority were aged 13–17. Measures quantifying quality of life (PEDS-QL generic and diabetes specific modules...